EUVIMEDSkopri EUVIMED
Open access · CC BY-NC-ND 4.0

Development of Miniprotein Binders to Inhibit VEGF-Induced Corneal Neovascularization

Nana Aisha Adams, Miranda M Alaniz, Sahi Nandini Wuppukondur, Alexander W Schill, Zaccheaus O Alabi, Mehmet Sen, Vivien J Coulson-Thomas, Tarsis F Gesteira

Investigative Ophthalmology & Visual Science · 2026

DOI: 10.1167/iovs.67.5.61 ↗

At a glance

Journal article in Investigative Ophthalmology & Visual Science, 2026. Written by Nana Aisha Adams and 7 co-authors. Institution: College of Optometry, University of Houston, Houston, Texas, United States. Major MEDLINE topics: Corneal Neovascularization, Vascular Endothelial Growth Factor A, Angiogenesis Inhibitors. 67 references. The full text is freely available (open access, CC BY-NC-ND 4.0).

AstrattSubjectsDettalji biblijografiċiCiteRelated studies

Abstract (original language)

Purpose

Corneal neovascularization (CNV) disrupts corneal transparency and impairs vision and is driven primarily by vascular endothelial growth factor (VEGF-A165). Current therapies rely on off-label anti-VEGF agents, which are limited by poor corneal penetration and the need for repeated dosing. Herein, we aimed to rationally design and validate novel hyperstable VEGF-A165 miniprotein inhibitors against VEGF-A165 for preventing CNV.

Methods

VEGF-A165 miniprotein binders were generated using a de novo diffusion-based protein design protocol and expressed in Escherichia coli (E. coli). Selected candidates were characterized for binding activity via biophysical assays. Cytotoxicity was assessed in immortalized human corneal epithelial cells and primary human corneal fibroblasts. Anti-angiogenic efficacy was screened using in vitro angiogenic assays and validated in vivo using an alkali burn mouse model of CNV.

Results

Computational design yielded several VEGF-A165 minibinders, with Vmb-9 displaying the highest affinity (KD ≈ 6 nM). The minibinders were thermally stable (Tm > 85°C) and non-cytotoxic to corneal cells. The lead binder Vmb-9 reduced in vitro tube formation, achieving efficacy comparable to bevacizumab, and suppressed corneal hemangiogenesis and lymphangiogenesis in vivo following alkali burn (P < 0.05).

Conclusions

Vmb-9, a novel hyperstable VEGF-A165 minibinder, exhibited potent anti-angiogenic activity and effectively inhibited corneal neovascularization in vivo with topical application. Their small size, reduced immunogenicity, and scalable production highlight their potential as a next-generation therapeutic strategy that overcomes the limitations of conventional anti-VEGF treatments.

Subjects

MeSH terms (MEDLINE)

Corneal NeovascularizationVascular Endothelial Growth Factor AAngiogenesis InhibitorsAnimalsMiceHumansDisease Models, AnimalMice, Inbred C57BLCells, CulturedEpithelium, CornealBurns, Chemical

Substances

Vascular Endothelial Growth Factor AAngiogenesis InhibitorsVEGFA protein, human

Authors and institutions

  • College of Optometry, University of Houston, Houston, Texas, United States.
  • Department of Biology and Biochemistry, University of Houston, Houston, Texas, United States.

Cite

APA

Adams, N. A., Alaniz, M. M., Wuppukondur, S. N., Schill, A. W., Alabi, Z. O., Sen, M., Coulson-Thomas, V. J., & Gesteira, T. F. (2026). Development of Miniprotein Binders to Inhibit VEGF-Induced Corneal Neovascularization. Investigative Ophthalmology & Visual Science. https://doi.org/10.1167/iovs.67.5.61

Vancouver

Adams NA, Alaniz MM, Wuppukondur SN, Schill AW, Alabi ZO, Sen M, et al. Development of Miniprotein Binders to Inhibit VEGF-Induced Corneal Neovascularization. Investigative Ophthalmology & Visual Science. 2026. doi:10.1167/iovs.67.5.61

BibTeX
@article{Adams2026,
  author = {Adams, Nana Aisha and Alaniz, Miranda M and Wuppukondur, Sahi Nandini and Schill, Alexander W and Alabi, Zaccheaus O and Sen, Mehmet and Coulson-Thomas, Vivien J and Gesteira, Tarsis F},
  title = {Development of Miniprotein Binders to Inhibit VEGF-Induced Corneal Neovascularization},
  journal = {Investigative Ophthalmology & Visual Science},
  year = {2026},
  doi = {10.1167/iovs.67.5.61}
}
Start for free →